MODIFICATION
B -- Extending ZIKA Emergency Response -PR2017-11600
- Notice Date
- 5/22/2017
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- PR99049ZIKA
- Archive Date
- 6/7/2017
- Point of Contact
- Thaddeus E Rollins, Phone: 770-488-1971
- E-Mail Address
-
tnr6@cdc.gov
(tnr6@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) Influenza Division (ID), intends to continue sole source ZIKA emergency response by extending current contract requirement period of performance and include additional funding in support ZIKA. CDC contract 200-2008-28045 was awarded in accordance with FAR Part 15- Acquisition by Negotiation to American Type Cultural Collection (ATCC), 10801 University Blvd Manassas, VA 20110-2204 ATCC is the current contractor of work being performed of a current contract. Under the Influenza Division's existing Influenza Reagent Resource (IRR) contract, ATCC has built substantial infrastructure to support the purchase, storage, distribution and tracking of ancillary reagents to specifically support CDC diagnostic testing. The EOC's projected needs for the anticipated ancillary reagent demand is over 14,000 items over the next year. This volume of reagents will require substantial cold storage space and a robust inventory system to track receipt and distribution. ATCC's repository facilities include 26,000 square feet of storage space, including 200+ liquid nitrogen tanks and mechanicals with multiple walk in freezers at +4°C, -20°C, and -80°C. Under the existing Influenza Division's IRR contract, ATCC has developed an extensive tracking system specifically designed for monitoring pending and completed shipments of CDC reagents to CDC's strategic laboratory partners in a manner that directly integrates with existing CDC databases. ATCC has built and now maintains an approved secure website for external laboratories partners to view available reagents and request support. To rebuild a duplicate reagent management and distribution mechanism for the Zika Emergency response with another contractor would be an estimated $1-2 million dollars in cost duplication to fund the new contractor's startup costs, require re-training of existing strategic laboratory partners to a new ordering system, and require 2-3 full time government staff to oversee the technical aspects of managing the project. These funds, staff, and time resources are simply not available to the Emergency Operation Center at this time. Another critical consideration is the fact that the reagents specifically included in this proposal have undergone laboratory qualification testing at CDC to ensure their optimization and direct compatibility with the CDC's in-house developed Zika Virus diagnostic assay. Use of unqualified extraction kits or enzymes by the laboratories performing Zika testing is not approved by the FDA under the terms of Emergency Use Authorization (EUA) granted to CDC on February 26, 2016. Use of unqualified reagents could alter the performance of the assay and inhibit its ability to detect the virus in human samples. The immediate nature of the current emergency response prevents the government from qualifying more extraction kits and enzymes than the reagents already validated at this time. Qualification of new reagents involves a battery of time-consuming laboratory testing to ensure that assay performance is not substantially reduced due to unknown inhibiting reagents that could be present in alternate vendors' formulations. It would also require resubmission of the entire EUA to the FDA for re-review and re-approval, adding more time to the timeline than can currently be accommodated. Because this is a sole source procurement, no solicitation will be posted to FedBizOpps. We will only issue a solicitation to ATCC. CDC anticipates soliciting and negotiating with only one source under the statutory authority 10 U.S.C. 2304(c)(1) permitting other than full and open competition in accordance with Federal Acquisition Regulation (FAR) Part 6.302-1 - Only one responsible source and no other supplies or services will satisfy agency requirements. CDC believes ATCC is the only source available to provide this service that meets the urgency and mission critical requirements. This notice of intent is not a request for proposal. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capability to satisfy this requirement should submit a capability statement demonstrating their ability to meet this requirement. All responses must be sent in writing to Mr. Thaddeus Rollins via email to tnr6@cdc.gov using the reference ATCC ZIKA Emergency Response in the subject line, no later than Noon Eastern Time, 06 June 2017.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/PR99049ZIKA/listing.html)
- Place of Performance
- Address: Contractor Facility, United States
- Record
- SN04517716-W 20170524/170522235246-101de0f84e40f043787388d5733aa510 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |